Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network

por Brizzi, Maria P, Berruti, Alfredo, Ferrero, Anna, Milanesi, Enrica, Volante, Marco, Castiglione, Federico, Birocco, Nadia, Bombaci, Sebastiano, Perroni, Davide, Ferretti, Benedetta, Alabiso, Oscar, Ciuffreda, Libero, Bertetto, Oscar, Papotti, Mauro, Dogliotti, Luigi
Publicado 2009